148 related articles for article (PubMed ID: 37336037)
21. Optimization of non-endorectal prostate MR image quality using PI-QUAL: A multidisciplinary team approach.
Robertson SH; Owenby E; Beasley C; Wall L; Gray B; Boru I; Kalisz KR; Kruse DE; Marin D; Thomas SP; Macdonald EB; Purysko AS; Gupta RT
Eur J Radiol; 2023 Sep; 166():110998. PubMed ID: 37506475
[TBL] [Abstract][Full Text] [Related]
22. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.
Gondo T; Hricak H; Sala E; Zheng J; Moskowitz CS; Bernstein M; Eastham JA; Vargas HA
Eur Radiol; 2014 Dec; 24(12):3161-70. PubMed ID: 25100337
[TBL] [Abstract][Full Text] [Related]
23. Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical Prostatectomy.
Dinneen E; Allen C; Strange T; Heffernan-Ho D; Banjeglav J; Lindsay J; Mulligan JP; Briggs T; Nathan S; Sridhar A; Grierson J; Haider A; Panayi C; Patel D; Freeman A; Aning J; Persad R; Ahmad I; Dutto L; Oakley N; Ambrosi A; Parry T; Kasivisvanathan V; Giganti F; Shaw G; Punwani S
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626214
[No Abstract] [Full Text] [Related]
24. Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.
Krishna S; McInnes M; Lim C; Lim R; Hakim SW; Flood TA; Schieda N
AJR Am J Roentgenol; 2017 Dec; 209(6):W365-W373. PubMed ID: 28981356
[TBL] [Abstract][Full Text] [Related]
25. Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy.
Brembilla G; Lavalle S; Parry T; Cosenza M; Russo T; Mazzone E; Pellegrino F; Stabile A; Gandaglia G; Briganti A; Montorsi F; Esposito A; De Cobelli F
Eur J Radiol; 2023 Jul; 164():110849. PubMed ID: 37141845
[TBL] [Abstract][Full Text] [Related]
26. Multi-reader evaluation of different image quality scoring systems in prostate MRI.
Hötker AM; Njoh S; Hofer LJ; Held U; Rupp NJ; Ghafoor S; Stocker D; Eberli D; Donati OF
Eur J Radiol; 2023 Apr; 161():110733. PubMed ID: 36780738
[TBL] [Abstract][Full Text] [Related]
27. Prostate Imaging Reporting and Data System, Version 2, Assessment Categories and Pathologic Outcomes in Patients With Gleason Score 3 + 4 = 7 Prostate Cancer Diagnosed at Biopsy.
Lim CS; McInnes MDF; Flood TA; Breau RH; Morash C; Thornhill RE; Schieda N
AJR Am J Roentgenol; 2017 May; 208(5):1037-1044. PubMed ID: 28267359
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the European Society of Urogenital Radiology (ESUR) PI-RADS scoring system for assessment of extra-prostatic extension in prostatic carcinoma.
Schieda N; Quon JS; Lim C; El-Khodary M; Shabana W; Singh V; Morash C; Breau RH; McInnes MD; Flood TA
Eur J Radiol; 2015 Oct; 84(10):1843-8. PubMed ID: 26137904
[TBL] [Abstract][Full Text] [Related]
29. Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.
Schimmöller L; Quentin M; Arsov C; Lanzman RS; Hiester A; Rabenalt R; Antoch G; Albers P; Blondin D
Eur Radiol; 2013 Nov; 23(11):3185-90. PubMed ID: 23756958
[TBL] [Abstract][Full Text] [Related]
30. Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
Schaudinn A; Gawlitza J; Mucha S; Linder N; Franz T; Horn LC; Kahn T; Busse H
Eur J Radiol; 2019 Jul; 116():180-185. PubMed ID: 31153562
[TBL] [Abstract][Full Text] [Related]
31. Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study.
Windisch O; Benamran D; Dariane C; Favre MM; Djouhri M; Chevalier M; Guillaume B; Oderda M; Gatti M; Faletti R; Colinet V; Lefebvre Y; Bodard S; Diamand R; Fiard G
Eur Urol Open Sci; 2023 Jan; 47():94-101. PubMed ID: 36601048
[TBL] [Abstract][Full Text] [Related]
32. Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship.
Giganti F; Cole AP; Fennessy FM; Clinton T; Moreira PLDF; Bernardes MC; Westin CF; Krishnaswamy D; Fedorov A; Wollin DA; Langbein B; Frego N; Labban M; Badaoui JS; Chang SL; Briggs LG; Tokuda J; Ambrosi A; Kirkham A; Emberton M; Kasivisvanathan V; Moore CM; Allen C; Tempany CM
Eur Radiol; 2023 Jan; 33(1):461-471. PubMed ID: 35771247
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of abbreviated multiparametric MRI-derived protocols in predicting local staging of prostate cancer in men undergoing radical prostatectomy.
Giannarini G; Cereser L; Como G; Bonato F; Pizzolitto S; Valotto C; Ficarra V; Dal Moro F; Zuiani C; Girometti R
Acta Radiol; 2021 Jul; 62(7):949-958. PubMed ID: 32718179
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
Lim CS; Abreu-Gomez J; Carrion I; Schieda N
AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
[No Abstract] [Full Text] [Related]
35. Taking PI-QUAL beyond the prostate: Towards a standardized radiological image quality score (RI-QUAL).
Becker AS; Giganti F; Purysko AS; Fainberg J; Vargas HA; Woo S
Eur J Radiol; 2023 Aug; 165():110955. PubMed ID: 37421773
[TBL] [Abstract][Full Text] [Related]
36. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
37. Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate.
Johnson PM; Tong A; Donthireddy A; Melamud K; Petrocelli R; Smereka P; Qian K; Keerthivasan MB; Chandarana H; Knoll F
J Magn Reson Imaging; 2022 Jul; 56(1):184-195. PubMed ID: 34877735
[TBL] [Abstract][Full Text] [Related]
38. Improving reader accuracy and specificity with the addition of hybrid multidimensional-MRI to multiparametric-MRI in diagnosing clinically significant prostate cancers.
Lee G; Chatterjee A; Harmath C; Karademir I; Engelmann R; Yousuf A; Islam S; Karczmar G; Oto A; Giurcanu M; Antic T; Eggener S
Abdom Radiol (NY); 2023 Oct; 48(10):3216-3228. PubMed ID: 37358605
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of prostate cancer in PI-RADS version 2.1 T2-weighted transition zone 'nodule in nodule' and 'homogeneous mildly hypointense area between nodules' criteria: MRI-radical prostatectomy histopathological evaluation.
Lim CS; Abreu-Gomez J; Flood TA; Carrion I; Dallaire FB; Schieda N
Eur Radiol; 2021 Oct; 31(10):7792-7801. PubMed ID: 33782767
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Utility of a Likert Scale Versus Qualitative Descriptors and Length of Capsular Contact for Determining Extraprostatic Tumor Extension at Multiparametric Prostate MRI.
Costa DN; Passoni NM; Leyendecker JR; de Leon AD; Lotan Y; Roehrborn CG; Otero-Muinelo S; Grewal H; Xi Y; Francis F; Rofsky NM; Pedrosa I
AJR Am J Roentgenol; 2018 May; 210(5):1066-1072. PubMed ID: 29489410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
